Drug Profile
Dalcetrapib companion diagnostic - DalCor/Roche
Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator DalCor Pharmaceuticals; Roche
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acute coronary syndromes
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for clinical-Phase-Unknown development in Acute coronary syndromes(Diagnosis) in USA
- 09 Jun 2015 Clinical trials in Acute coronary syndromes (Diagnosis) in USA (unspecified route)